Bluejay Diagnostics, Inc.
BJDX
$1.56
-$0.0799-4.87%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 3.70M | 3.87M | 4.00M | 4.36M | 4.60M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.17M | 8.07M | 9.05M | 10.06M | 10.31M |
| Operating Income | -7.17M | -8.07M | -9.05M | -10.06M | -10.31M |
| Income Before Tax | -7.72M | -8.59M | -9.40M | -9.74M | -9.95M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.72 | -8.59 | -9.40 | -9.74 | -9.95 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.72M | -8.59M | -9.40M | -9.74M | -9.95M |
| EBIT | -7.17M | -8.07M | -9.05M | -10.06M | -10.31M |
| EBITDA | -7.09M | -7.99M | -8.74M | -9.51M | -9.66M |
| EPS Basic | -35.57 | -7.75 | -- | -- | -- |
| Normalized Basic EPS | -6.55 | -4.85 | -- | -- | -- |
| EPS Diluted | -35.57 | -7.75 | -- | -- | -- |
| Normalized Diluted EPS | -6.55 | -4.85 | -- | -- | -- |
| Average Basic Shares Outstanding | 718.00K | 191.10K | -- | -- | -- |
| Average Diluted Shares Outstanding | 718.00K | 191.10K | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |